SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K/A
(Amendment No. 1)
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED) July 31, 2003
Inverness Medical Innovations, Inc.
(Exact Name of Registrant as Specified in Its Charter)
| Delaware (State or other jurisdiction of incorporation) |
001-16789 (Commission file number) |
04-3565120 (IRS Employer Identification No.) |
51 Sawyer Road, Suite 200, Waltham, Massachusetts 02453
(Address of principal executive offices)
Registrant's telephone number, including area code: (781) 647-3900
Not Applicable
(Former name or former address, if changed since last report)
Inverness Medical Innovations, Inc. (the "Company") hereby amends its Current Report on Form 8-K, event date July 31, 2003, in order to add as exhibits certain additional materials relating to its releases, by press release and conference call, regarding the Company's financial results for the quarter ended June 30, 2003.
| Exhibit Number |
Description |
|
|---|---|---|
| 99.1 | Press Release dated July 31, 2003, entitled "Inverness Medical Innovations Announces Second Quarter Results" | |
99.2 |
Transcript of conference call held on July 31, 2003 to discuss second quarter results |
|
99.3 |
Supplemental Reconciliation of Non-GAAP Financial Measures |
ITEM 12. RESULTS OF OPERATIONS AND FINANCIAL CONDITION
On July 31, 2003, Inverness Medical Innovations, Inc. issued a press release entitled "Inverness Medical Innovations Announces Second Quarter Results," a copy of which is furnished with this Current Report on Form 8-K as Exhibit 99.1. On July 31, 2003, the Company also held a conference call to discuss its second quarter results. A transcript of the conference call, as well as a reconciliation of certain non-GAAP financial measures disclosed during the conference call, are furnished with this Current Report on Form 8-K as Exhibits 99.2 and 99.3, respectively.
2
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| INVERNESS MEDICAL INNOVATIONS, INC. | ||||
BY: |
/s/ JAY MCNAMARA Jay McNamara Associate General Counsel |
|||
Dated: August 6, 2003
3
| Exhibit Number |
Description |
|
|---|---|---|
| 99.1 | Press Release dated July 31, 2003, entitled "Inverness Medical Innovations Announces Second Quarter Results" | |
99.2 |
Transcript of conference call held on July 31, 2003 to discuss second quarter results |
|
99.3 |
Supplemental Reconciliation of Non-GAAP Financial Measures |
4